Annual Accounts Receivable
$17.90 M
-$64.57 M-78.30%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual accounts receivable is $17.90 million, with the most recent change of -$64.57 million (-78.30%) on December 31, 2023.
- During the last 3 years, DNA annual accounts receivable has risen by +$1.21 million (+7.22%).
- DNA annual accounts receivable is now -86.39% below its all-time high of $131.54 million, reached on December 31, 2021.
Performance
DNA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$23.41 M
+$4.82 M+25.94%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly accounts receivable is $23.41 million, with the most recent change of +$4.82 million (+25.94%) on September 30, 2024.
- Over the past year, DNA quarterly accounts receivable has increased by +$5.51 million (+30.80%).
- DNA quarterly accounts receivable is now -86.36% below its all-time high of $171.62 million, reached on June 30, 2022.
Performance
DNA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
DNA Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.3% | +30.8% |
| 3 y3 years | +7.2% | +30.8% |
| 5 y5 years | - | - |
DNA Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.4% | at low | -86.4% | +30.8% |
| 5 y | 5-year | -86.4% | +7.2% | -86.4% | +40.2% |
| alltime | all time | -86.4% | +7.2% | -86.4% | +40.2% |
Ginkgo Bioworks Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.41 M(+25.9%) |
| Jun 2024 | - | $18.59 M(-23.2%) |
| Mar 2024 | - | $24.19 M(+35.1%) |
| Dec 2023 | $17.90 M(-78.3%) | $17.90 M(-71.1%) |
| Sep 2023 | - | $61.90 M(-9.0%) |
| Jun 2023 | - | $68.02 M(-18.3%) |
| Mar 2023 | - | $83.26 M(+1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $82.47 M(-37.3%) | $82.47 M(-27.4%) |
| Sep 2022 | - | $113.66 M(-33.8%) |
| Jun 2022 | - | $171.62 M(+2.6%) |
| Mar 2022 | - | $167.26 M(+27.1%) |
| Dec 2021 | $131.54 M(+688.0%) | $131.54 M(+194.4%) |
| Sep 2021 | - | $44.67 M(+167.6%) |
| Dec 2020 | $16.69 M | $16.69 M |
FAQ
- What is Ginkgo Bioworks Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual accounts receivable year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly accounts receivable year-on-year change?
What is Ginkgo Bioworks Holdings annual accounts receivable?
The current annual accounts receivable of DNA is $17.90 M
What is the all time high annual accounts receivable for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual accounts receivable is $131.54 M
What is Ginkgo Bioworks Holdings annual accounts receivable year-on-year change?
Over the past year, DNA annual accounts receivable has changed by -$64.57 M (-78.30%)
What is Ginkgo Bioworks Holdings quarterly accounts receivable?
The current quarterly accounts receivable of DNA is $23.41 M
What is the all time high quarterly accounts receivable for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly accounts receivable is $171.62 M
What is Ginkgo Bioworks Holdings quarterly accounts receivable year-on-year change?
Over the past year, DNA quarterly accounts receivable has changed by +$5.51 M (+30.80%)